Company / Gross Profit
TENAX THERAPEUTICS, INC. Gross Profit History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
-$104.1K
FY2016
5-year range
-$104.1K / $49.6K
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $49,572 to -$104,069 over the past 2 years.
Based on SEC 10-K filings.
-$104,069 in FY2016.
Declined from $49,572 to -$104,069 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, gross profit increased 0.0% year-over-year.
- Peak gross profit was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2016 | -$104.1K | +0.0% |
| FY2015 | -$104.1K | -309.9% |
| FY2014 | $49.6K | +0.6% |
| FY2013 | $49.3K | -52.2% |
| FY2012 | $103.2K | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026